What is the recommended treatment for typhoid fever?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Typhoid Fever

Ceftriaxone is the recommended first-line treatment for typhoid fever due to its high efficacy and lower resistance rates, with azithromycin as a suitable alternative, particularly in regions with high fluoroquinolone resistance. 1

First-line Treatment Options

Ceftriaxone

  • Dosage: 50-80 mg/kg/day for 7-10 days 1
  • Advantages:
    • High efficacy against Salmonella typhi
    • Low resistance rates globally
    • Suitable for severe infections or when oral therapy isn't possible
    • Safe alternative during pregnancy 1
  • All isolates reported to the UK Health Protection Agency are sensitive to ceftriaxone 1

Azithromycin

  • Preferred alternative treatment option
  • Lower risk of clinical failure compared to fluoroquinolones 1
  • Lower relapse rates (<3%) compared to ceftriaxone (<8%) 1
  • Especially suitable for:
    • Children and pregnant women due to its safety profile
    • Regions with high fluoroquinolone resistance 1

Treatment Selection Based on Resistance Patterns

Strain Recommended Treatment Alternative Options
Fully sensitive Azithromycin Fluoroquinolones, chloramphenicol, amoxicillin, trimethoprim-sulfamethoxazole
Multidrug-resistant Fluoroquinolones or cefixime Azithromycin
Quinolone-resistant Azithromycin or ceftriaxone Cefixime

Important Clinical Considerations

  • Treatment duration: Continue treatment for 14 days to reduce relapse risk 1
  • Expected response:
    • Fever clearance typically occurs within 4 days of appropriate treatment
    • Clinical improvement usually within 48-72 hours 1
  • Monitoring: Closely observe patients for clinical response, particularly when using medications with higher failure rates (e.g., cefixime) 1

Fluoroquinolone Considerations

  • Ciprofloxacin is FDA-approved for typhoid fever caused by Salmonella typhi 2
  • However, its use is limited by high resistance rates:
    • More than 70% of Salmonella typhi isolates imported to the UK are resistant to fluoroquinolones 1
    • Should be used with caution, particularly for travelers to South and Southeast Asia 1
    • Should be avoided in children and pregnant women when possible 1
  • If susceptibility is confirmed, ciprofloxacin can be used at 15 mg/kg twice daily (maximum 500 mg twice daily) for 7-10 days 1

Cautions and Pitfalls

  • Resistance testing: Using ciprofloxacin discs alone to determine Salmonella typhi sensitivity is unreliable; the organism should also be sensitive to nalidixic acid on disc testing 1
  • Diagnostic limitations: The serological Widal test lacks sensitivity and specificity and is not recommended for diagnosis 1
  • Avoid antimotility agents such as loperamide in patients with high fever or blood in stool 1
  • Cefixime caution: Has reported treatment failure rates of 4-37.6%, making it less reliable than other options 1

Prevention Recommendations

  • Typhoid vaccination for travelers to endemic areas
  • Proper hand hygiene and food safety practices
  • Avoiding high-risk foods and beverages in endemic areas 1
  • Asymptomatic carriers in healthcare or food service should be treated according to public health guidance 1

The emergence of extensively drug-resistant strains of typhoid fever, particularly in South Asia, highlights the importance of appropriate antibiotic selection based on local resistance patterns and susceptibility testing when available.

References

Guideline

Typhoid Fever Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.